The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 72, Issue 4, Pages 619-625
Publisher
Wiley
Online
2017-09-15
DOI
10.1111/his.13399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma
- (2016) Radhika Srinivasan et al. Indian Journal of Pathology and Microbiology
- Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum
- (2015) Naveena Singh et al. HISTOPATHOLOGY
- Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
- (2015) Steffen Böhm et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
- (2015) W Glenn McCluggage et al. MODERN PATHOLOGY
- Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal
- (2014) Naveena Singh et al. HISTOPATHOLOGY
- Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
- (2013) R. J. Kurman ANNALS OF ONCOLOGY
- Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery
- (2013) Miho Muraji et al. GYNECOLOGIC ONCOLOGY
- Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer
- (2011) Johanna Hynninen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
- (2011) Gordon John Sampson Rustin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
- (2010) Christopher G. Przybycin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started